Annual Operating Expenses
$55.79 M
-$73.69 M-56.91%
December 31, 2024
Summary
- As of March 8, 2025, ACRS annual total operating expenses is $55.79 million, with the most recent change of -$73.69 million (-56.91%) on December 31, 2024.
- During the last 3 years, ACRS annual operating expenses has fallen by -$11.64 million (-17.27%).
- ACRS annual operating expenses is now -56.91% below its all-time high of $129.48 million, reached on December 31, 2023.
Performance
ACRS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$13.98 M
+$2.37 M+20.42%
December 31, 2024
Summary
- As of March 8, 2025, ACRS quarterly total operating expenses is $13.98 million, with the most recent change of +$2.37 million (+20.42%) on December 31, 2024.
- Over the past year, ACRS quarterly operating expenses has increased by +$2.37 million (+20.42%).
- ACRS quarterly operating expenses is now -59.90% below its all-time high of $34.86 million, reached on December 31, 2023.
Performance
ACRS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ACRS Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.9% | +20.4% |
| 3 y3 years | -17.3% | -33.6% |
| 5 y5 years | -39.4% | +0.7% |
ACRS Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.9% | at low | -59.9% | +20.4% |
| 5 y | 5-year | -56.9% | +11.9% | -59.9% | +38.4% |
| alltime | all time | -56.9% | +961.2% | -59.9% | +438.5% |
Aclaris Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $55.79 M(-56.9%) | $13.98 M(+20.4%) |
| Sep 2024 | - | $11.61 M(-14.1%) |
| Jun 2024 | - | $13.51 M(-19.0%) |
| Mar 2024 | - | $16.69 M(-52.1%) |
| Dec 2023 | $129.48 M(+25.8%) | $34.86 M(+13.6%) |
| Sep 2023 | - | $30.67 M(-5.8%) |
| Jun 2023 | - | $32.57 M(+3.8%) |
| Mar 2023 | - | $31.38 M(+11.2%) |
| Dec 2022 | $102.95 M(+52.7%) | $28.22 M(-4.2%) |
| Sep 2022 | - | $29.47 M(+18.6%) |
| Jun 2022 | - | $24.85 M(+21.8%) |
| Mar 2022 | - | $20.41 M(-3.0%) |
| Dec 2021 | $67.43 M(+35.2%) | $21.05 M(+5.5%) |
| Sep 2021 | - | $19.95 M(+44.9%) |
| Jun 2021 | - | $13.77 M(+8.7%) |
| Mar 2021 | - | $12.66 M(-8.6%) |
| Dec 2020 | $49.87 M(-45.8%) | $13.85 M(+37.2%) |
| Sep 2020 | - | $10.10 M(-16.1%) |
| Jun 2020 | - | $12.04 M(-13.3%) |
| Mar 2020 | - | $13.88 M(-17.8%) |
| Dec 2019 | $91.99 M | $16.89 M(-26.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $23.02 M(-7.9%) |
| Jun 2019 | - | $24.99 M(-7.8%) |
| Mar 2019 | - | $27.11 M(+4.1%) |
| Dec 2018 | $86.60 M(+60.9%) | $26.05 M(+21.8%) |
| Sep 2018 | - | $21.39 M(-35.1%) |
| Jun 2018 | - | $32.97 M(+6.0%) |
| Mar 2018 | - | $31.10 M(+307.9%) |
| Dec 2017 | $53.84 M(+11.5%) | $7.63 M(-59.8%) |
| Sep 2017 | - | $18.99 M(+32.8%) |
| Jun 2017 | - | $14.29 M(+10.6%) |
| Mar 2017 | - | $12.93 M(+14.2%) |
| Dec 2016 | $48.27 M(+133.5%) | $11.33 M(+4.8%) |
| Sep 2016 | - | $10.81 M(-16.8%) |
| Jun 2016 | - | $12.99 M(-1.1%) |
| Mar 2016 | - | $13.14 M(+173.6%) |
| Dec 2015 | $20.67 M(+142.2%) | $4.80 M(-54.9%) |
| Sep 2015 | - | $10.64 M(+309.9%) |
| Jun 2015 | - | $2.60 M(-1.3%) |
| Mar 2015 | - | $2.63 M(+1.0%) |
| Dec 2014 | $8.53 M(+62.3%) | $2.60 M(-2.3%) |
| Sep 2014 | - | $2.66 M |
| Dec 2013 | $5.26 M | - |
FAQ
- What is Aclaris Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual operating expenses year-on-year change?
- What is Aclaris Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly operating expenses year-on-year change?
What is Aclaris Therapeutics annual total operating expenses?
The current annual operating expenses of ACRS is $55.79 M
What is the all time high annual operating expenses for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual total operating expenses is $129.48 M
What is Aclaris Therapeutics annual operating expenses year-on-year change?
Over the past year, ACRS annual total operating expenses has changed by -$73.69 M (-56.91%)
What is Aclaris Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ACRS is $13.98 M
What is the all time high quarterly operating expenses for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly total operating expenses is $34.86 M
What is Aclaris Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ACRS quarterly total operating expenses has changed by +$2.37 M (+20.42%)